BLTE
Belite Bio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BLTE fundamentals
Belite Bio (BLTE) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.65 (YoY -132.14%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.65
-132.14%
Report date
Nov 10, 2025
BLTE Earnings Call Summary for Q3,2025
- Clinical Milestones: Completed Phase III enrollment for GA and Stargardt's disease, with DRAGON trial top-line data expected by end of November.
- Regulatory Progress: Secured priority review in China and conditional authorization in the UK, with global submissions planned for H1 2026.
- Funding Strength: $275.6 million cash post-Q3, supported by $175 million in recent financings and potential $165 million from warrant exercises.
- Commercialization Plan: Targeting U.S. launch with 20-40-person sales force, estimating $200 million in commercialization costs.
- Financial Health: Q3 net loss of $21.7 million driven by non-cash expenses, with stable operating cash outflow of $9.3 million.
EPS
Revenue
Revenue & Expenses
Key Indicators
Belite Bio (BLTE) key financial stats and ratios, covering profitability, financial health, and leverage.
Belite Bio (BLTE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Belite Bio (BLTE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Belite Bio (BLTE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Belite Bio (BLTE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Belite Bio (BLTE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Belite Bio's revenue and profit?What guidance did Belite Bio's management provide for the next earnings period?What is Belite Bio's gross profit margin?What is the revenue and EPS growth rate for Belite Bio year over year?Did Belite Bio beat or miss consensus estimates last quarter?What were the key takeaways from Belite Bio’s earnings call?What is Belite Bio's latest dividend and current dividend yield?What were the key takeaways from Belite Bio's earnings call?
